Inga Rossion
Papers
1
Total Citations
11
H-Index
1
About
Inga Rossion is a clinical researcher whose work centers on advancing surgical oncology, with a particular focus on pancreatic surgery and minimally invasive techniques. Her major contribution lies in the design and execution of high-impact clinical trials that rigorously evaluate surgical outcomes. She is best known for her leadership in the DISPACT-2 trial, a landmark randomised controlled trial comparing postoperative complications between minimally invasive and open distal pancreatectomy. This protocol paper, published in 2021 and already cited 11 times, addresses a critical gap in evidence-based surgery, challenging assumptions about the benefits of minimally invasive approaches. Rossion’s work is notable for its methodological rigor and its direct influence on surgical practice, helping to define safer, more effective treatment pathways for patients undergoing pancreatic resections. Her research not only quantifies complication rates but also informs clinical decision-making in a field where morbidity remains high. Through her contributions, Rossion has become a key voice in the movement toward evidence-based minimally invasive surgery, shaping how future surgeons approach complex procedures.
Research Focus
Key Achievements
Top Papers
- 1